Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma
Clinical trial NCT01921790 · UNKNOWN
Trial details
- NCT number
- NCT01921790
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2015-08-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.